Med BioGene Appoints Diagnostics Industry Veteran Dr. Heiner Dreismann
to Board of Directors
May 29, 2008 Dear Shareholder: I would like to bring to your attention today's news release where MBI announces that Heiner Dreismann, Ph.D. has joined the Board of Directors. Dr. Dreismann is the former Chief Executive Officer of Roche Molecular Diagnostics (Roche), a division of F. Hoffmann-La Roche Ltd. Under Dr. Dreismann’s leadership as Chief Executive Officer, Roche evolved into one of the world’s leading molecular diagnostics companies with annual sales to over US $1 billion and the significant expansion of their portfolio of diagnostic tests and hardware. Dr. Dreismann is one of the top industry experts in the field of molecular diagnostics. He has a proven track-record of leadership in the development, commercialization and adoption of molecular diagnostics and brings to Med BioGene valuable experience and industry contacts. We are very pleased to welcome him to our team. Click here to read the full news release. Thank you for your interest and support. Please call me if you have any questions or wish to discuss. Erinn B. Broshko
Chief Executive Officer
(604) 306-4969
ebroshko@medbiogene.com
www.medbiogene.com For investor relations information, please contact:
Certain statements made herein contain forward-looking information under applicable Canadian securities legislation. It is strongly suggested that you read our legal disclaimer by clicking here. | 
Home 
